The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK

As-needed budesonide/formoterol is effective in patients with mild asthma for whom low-dose inhaled corticosteroid (ICS) maintenance therapy is appropriate. We assessed the cost-effectiveness of this regimen versus maintenance low-dose ICS plus as-needed short-acting β2-agonist (SABA).

Source: Respiratory Medicine - July 3, 2020 Category: Respiratory Medicine Authors: J. Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, Danny Gibson, Karen Coulton, Kirsty Hounsell, Sarowar Golam, Mohsen Sadatsafavi Source Type: research